Send me real-time posts from this site at my email

May 3 - Trading List: Updates, Analyst Actions, Our Take - IOVA, SGMO

Iovance Biotherapeutics initiated with a Buy at Truist

Truist analyst Asthika Goonewardene initiated coverage of Iovance Biotherapeutics with a Buy rating and $50 price target. The company is a "lone front runner" in the tumor infiltrating lymphocyte space, having demonstrated efficacy in solid tumors while developing a proprietary streamlined manufacturing process that is commercially feasible, the analyst tells investors in a research note. Goonewardene adds that the melanoma and cervical cancer indication data in the company's lead TIL therapy have been "very compelling".

Our Take:  "On our trading list and currently undervalued. Moderate risk with a huge upside potential. Buy any dips."

$IOVA, Iovance Biotherapeutics, Inc. / H1

Sangamo initiated with an Outperform at RBC Capital

RBC Capital analyst Luca Issi initiated coverage of Sangamo with an Outperform rating and $22 price target. Sangamo has "trail blazed the field of gene-editing using zinc finger proteins," which is "being overlooked now that Crispr is getting most of the headlines," Issi tells investors. However, Sangamo has a potential best-in-class wholly-owned program for Fabry disease as well as partnered programs that have already shown proof of concept, Issi said.

Our Take:  "Very good pick off of our favorites list. A strong buy at it's current levels."

Trade Idea:  Sell some $12 strike puts along with buying the stock.

$SGMO, Sangamo Therapeutics, Inc. / H1

Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal.

If you liked this article, please click the LIKE (thumbs up) button.

Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so)!

Follow us/bookmark us and check back occasionally for additional articles or comments on our page...

Wild Tiger Trading - start/main page.


Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue